CjC-1295 no DAC 5mg

Comprehensive Guide to CJC-1295 Without DAC 5mg (Mod GRF 1-29): Growth Hormone-Releasing Hormone Analogue Structure, Pituitary Research Standards, and Analytical Purity

Welcome to Suzhou Lanhai Peptide, your trusted global source for advanced synthetic peptides, amino acid derivatives, and specialized laboratory storage solutions. In modern endocrinology research, pituitary pulsatile signaling studies, and advanced pharmaceutical formulation research, investigating targeted growth hormone-releasing hormone (GHRH) analogues requires absolute precision, verifiable purity, and strict compliance with research standards. When exploring episodic growth hormone secretion, somatotroph receptor kinetics, and short-half-life secretagogue dynamics, utilizing high-purity CJC-1295 Without DAC 5mg (commonly known as Mod GRF 1-29) is vital for achieving reproducible scientific outcomes.

This comprehensive guide explores the structural sequence, biochemical properties, analytical verification standards, and proper laboratory storage protocols for CJC-1295 No DAC 5mg. By examining real-world industry benchmarks and analytical chemistry standards, we outline why optimized sourcing and handling are fundamental to advanced metabolic and endocrine research.

1. Understanding CJC-1295 Without DAC: Structure, Mechanism, and Research Scope

CJC-1295 without DAC (also known as Modified GRF 1-29 or tetrasubstituted human growth hormone-releasing factor 1-29) is a synthetic 29-amino acid peptide analogue modeled after endogenous GHRH. Its specific amino acid substitutions (Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2) are engineered to enhance enzymatic resistance against dipeptidyl peptidase-4 (DPP-4) degradation while omitting the Drug Affinity Complex (DAC) lysine linker.

The Mechanism of Action in Biomedical Research

In contemporary biochemical and pharmacological investigations, CJC-1295 No DAC is examined for several key cellular pathways:

• Selective GHRH Receptor Agonism: Mod GRF 1-29 binds selectively to growth hormone-releasing hormone receptors (GHRHR) located on the surface of pituitary somatotroph cells, stimulating cyclic AMP (cAMP) intracellular signaling cascades.

• Pulsatile Growth Hormone Secretion: Unlike versions featuring Drug Affinity Complex (DAC) which create prolonged plasma binding and steady-state elevation, CJC-1295 No DAC mirrors natural physiological pulsatile release patterns, exhibiting a shorter terminal half-life (approximately 30 minutes) suitable for controlled episodic release studies.

• Synergistic Endocrine Modeling: In vitro and animal model research evaluates its synergistic pairing with growth hormone secretagogues (such as GHRP-6 or Ipamorelin) to investigate amplified pituitary responsiveness and somatotroph reserve capacity.

2. Analytical Verification and High-Purity Synthesis Standards

For institutional buyers, academic researchers, and biotechnology procurement managers, batch verification is paramount. Specialized peptide analogues containing D-amino acid substitutions and amide modifications require rigorous solid-phase peptide synthesis (SPPS) and HPLC purification to prevent sequence truncation or stereoisomeric impurities.

High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS)

Every batch of CJC-1295 No DAC 5mg distributed by Suzhou Lanhai Peptide undergoes rigorous verification via HPLC and MS to guarantee purity levels exceeding 98% to 99%+, ensuring minimal synthetic impurities, deletion sequences, or degradation byproducts.

Technical Specification Comparison

3. Laboratory Handling, Reconstitution, and Storage Protocols

Synthetic peptides like CJC-1295 No DAC are supplied as stabilized, vacuum-freeze-dried (lyophilized) powders to maximize shelf-life stability. Proper laboratory handling is essential to preserve peptide integrity upon reconstitution.

Reconstitution Best Practices

• Solvent Selection: Reconstitute lyophilized CJC-1295 No DAC 5mg using sterile bacteriostatic water for injection or analytical buffer solutions in a clean laminar flow hood.

• Avoiding Shear Stress: Introduce solvents gently down the inside wall of the vial rather than forcefully spraying liquid directly onto the lyophilized cake to prevent peptide bond shearing.

Cold-Chain Storage Guidelines

• Dry Powder Storage: Store sealed vials of lyophilized CJC-1295 No DAC at $-20^\circ C$ desiccated away from light and moisture.

• Reconstituted Storage: Once reconstituted, solutions should be kept between $2^\circ C$ and $8^\circ C$ protected from light and utilized within short-term experimental windows to prevent enzymatic degradation or oxidation.

4. Mandatory Research Disclaimer and Compliance

• For Laboratory and Research Use Only: All peptide products offered by Suzhou Lanhai Peptide, including CJC-1295 No DAC 5mg, are strictly intended for in vitro laboratory research, analytical testing, and scientific study. They are not approved for human consumption, clinical trials on humans, veterinary use, or therapeutic self-administration.

5. Frequently Asked Questions (FAQs)

1. What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 with DAC features a covalent affinity complex that binds serum albumin for a prolonged half-life (days), whereas CJC-1295 without DAC (Mod GRF 1-29) lacks DAC, resulting in a short half-life (~30 minutes) that promotes natural pulsatile GH release patterns.

2. What purity level does Suzhou Lanhai Peptide guarantee for CJC-1295 No DAC 5mg?

Every batch of CJC-1295 No DAC 5mg is backed by analytical documentation confirming an HPLC purity rating of 98% to 99% or higher.

3. How should lyophilized CJC-1295 No DAC 5mg be stored prior to reconstitution?

Vials of dry powder should be stored tightly sealed in a dry environment at $-20^\circ C$ protected from light to maintain structural stability.

4. Are Certificates of Analysis (COAs) provided with orders?

Yes. Every order includes or provides access to batch-specific HPLC and Mass Spectrometry reports to verify purity and molecular weight for institutional compliance.

5. Can CJC-1295 No DAC be used in human clinical applications?

No. All products sold by Suzhou Lanhai Peptide are restricted strictly to laboratory research and development use only and are prohibited from human or clinical application.